Total Payments
$143,174
2024 Payments
$12,191
Companies
45
Transactions
854
Medicare Patients
4,396
Medicare Billing
$777,150
Payment Breakdown by Category
Other$118,375 (82.7%)
Food & Beverage$23,381 (16.3%)
Travel$945.04 (0.7%)
Education$473.10 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $118,375 | 46 | 82.7% |
| Food and Beverage | $23,381 | 791 | 16.3% |
| Travel and Lodging | $945.04 | 2 | 0.7% |
| Education | $473.10 | 15 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $125,450 | 261 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,261 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,015 | 102 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,985 | 79 | $0 (2024) |
| ViiV Healthcare Company | $1,600 | 1 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $671.13 | 32 | $0 (2024) |
| Insmed, Inc. | $635.03 | 22 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $593.62 | 27 | $0 (2020) |
| Mylan Specialty L.P. | $517.34 | 27 | $0 (2024) |
| Genentech USA, Inc. | $489.58 | 28 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,191 | 77 | GlaxoSmithKline, LLC. ($10,172) |
| 2023 | $30,333 | 118 | GlaxoSmithKline, LLC. ($27,878) |
| 2022 | $33,505 | 121 | GlaxoSmithKline, LLC. ($30,968) |
| 2021 | $28,187 | 108 | GlaxoSmithKline, LLC. ($26,575) |
| 2020 | $12,262 | 82 | GlaxoSmithKline, LLC. ($11,106) |
| 2019 | $20,904 | 119 | GlaxoSmithKline, LLC. ($17,342) |
| 2018 | $3,026 | 130 | GlaxoSmithKline, LLC. ($674.90) |
| 2017 | $2,767 | 99 | GlaxoSmithKline, LLC. ($733.20) |
All Payment Transactions
854 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $99.18 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $91.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: ANTIBIOTIC | ||||||
| 11/13/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $94.95 | General |
| Category: Immunology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Airway Clearance Device | ||||||
| 10/29/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), OPSUMIT, UPTRAVI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 10/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,061 | 2,196 | $640,675 | $180,219 |
| 2022 | 12 | 1,296 | 2,805 | $792,160 | $203,241 |
| 2021 | 13 | 1,104 | 2,504 | $767,009 | $203,211 |
| 2020 | 15 | 935 | 1,945 | $711,437 | $190,479 |
Total Patients
4,396
Total Services
9,450
Medicare Billing
$777,150
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 276 | 967 | $230,146 | $66,234 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 387 | $136,998 | $39,580 | 28.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 125 | 345 | $118,335 | $35,694 | 30.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 155 | 164 | $75,768 | $18,294 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $29,430 | $7,615 | 25.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 55 | 58 | $10,382 | $2,625 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $8,092 | $2,612 | 32.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 55 | 58 | $9,860 | $2,598 | 26.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 39 | 54 | $7,074 | $2,345 | 33.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 55 | 58 | $11,020 | $1,791 | 16.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 34 | $3,570 | $831.72 | 23.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 377 | 1,437 | $342,006 | $87,135 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 369 | $130,626 | $37,238 | 28.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 130 | 336 | $115,248 | $28,503 | 24.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 220 | 236 | $109,032 | $26,409 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $26,705 | $6,787 | 25.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 89 | 125 | $16,375 | $4,202 | 25.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 56 | 57 | $10,203 | $2,715 | 26.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 56 | 57 | $9,690 | $2,591 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $7,140 | $2,331 | 32.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 55 | 55 | $10,450 | $1,737 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 17 | $4,454 | $1,426 | 32.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 13 | 13 | $6,136 | $1,101 | 17.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 35 | 39 | $4,095 | $1,065 | 26.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 309 | 1,265 | $301,070 | $80,185 | 26.6% |
About Ignacio Cendan
Ignacio Cendan is a Pulmonary Disease healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194711861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ignacio Cendan has received a total of $143,174 in payments from pharmaceutical and medical device companies, with $12,191 received in 2024. These payments were reported across 854 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($118,375).
As a Medicare-enrolled provider, Cendan has provided services to 4,396 Medicare beneficiaries, totaling 9,450 services with total Medicare billing of $777,150. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Miami, FL
- Active Since 09/27/2005
- Last Updated 02/20/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1194711861
Products in Payments
- NUCALA (Biological) $67,928
- TRELEGY ELLIPTA (Drug) $30,112
- OFEV (Drug) $2,192
- UPTRAVI (Drug) $816.19
- ACTHAR (Biological) $780.84
- FASENRA (Biological) $772.91
- BREZTRI (Drug) $745.36
- AVYCAZ (Drug) $720.85
- OPSUMIT (Drug) $713.65
- Arikayce (Drug) $629.99
- DUPIXENT (Biological) $611.79
- FASENRA (Drug) $522.83
- SYMBICORT (Drug) $461.81
- Monarch Platform (Device) $413.30
- INCRUSE (Drug) $406.06
- BEVESPI AEROSPHERE (Drug) $351.71
- OPSUMIT MACITENTAN (Drug) $340.88
- Yupelri (Drug) $330.28
- GLASSIA (Biological) $318.16
- Esbriet (Biological) $318.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Miami
Dr. James Krainson, M.d.f.c.c.p, M.D.F.C.C.P
Pulmonary Disease — Payments: $412,346
Pulmonary Disease $412,346
Dr. Raul Valor, M.d, M.D
Pulmonary Disease — Payments: $310,164
Pulmonary Disease $310,164
Shirin Shafazand, Md, MD
Pulmonary Disease — Payments: $221,352
Pulmonary Disease $221,352
Dr. Jaime Avecillas, Md, MD
Pulmonary Disease — Payments: $77,524
Pulmonary Disease $77,524
Jose Birriel, Md, MD
Pulmonary Disease — Payments: $48,294
Pulmonary Disease $48,294
Adam Wanner, Md, MD
Pulmonary Disease — Payments: $42,402
Pulmonary Disease $42,402